QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients

202316 citationsJournal Article

Authors

José Otto Reusing · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Fabiana Agena · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Camille N. Kotton · Massachusetts General Hospital

Gustavo Campana · DuPont (Brazil)

Lı́gia Camera Pierrotti · Universidade de São Paulo

Elias David‐Neto · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Abstract

Guided CMV prevention by the prediction model with QFCMV is cost-effective and would spare from CMV surveillance in 42% of patients with low risk for CS-CMV.

Topics & Keywords

Cytomegalovirus and herpesvirus research Parvovirus B19 Infection Studies Herpesvirus Infections and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Transplantation

Volume 108, Issue 4, pp. 985-995

DOI: 10.1097/tp.0000000000004870

Field-Weighted Citation Impact: 3.54